PARP9 and prostate neoplasm: Previous studies have shown that PARP9 is overexpressed in a series of solid tumors, such as breast tumors,12 prostate tumors,11 diffuse large B cell lymphomas,13 and cervical tumors,14 and PARP9 may promote metastasis, recurrence and chemotherapy resistance in these tumors.